65 results
424B5
PCSA
Processa Pharmaceuticals Inc
28 May 24
Prospectus supplement for primary offering
4:49pm
to time.
Voting Rights. Each outstanding share of our common stock is entitled to one vote on all matters submitted to a vote of stockholders … cumulative voting rights.
Liquidation Rights. In the event of any liquidation, dissolution or winding up of the Company, the holders of our common
8-K
EX-4.3
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
. Miscellaneous.
a) No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
8-K
EX-4.2
6bibl8ga8ta3wv
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
EX-4.1
khr3z6 tab
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
424B4
yqk7ln
29 Jan 24
Prospectus supplement with pricing info
4:15pm
8-K
EX-3.1
dsqca d38x
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
EX-3.1
8nv8 swrt8j3fcx7t0
29 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:18pm